Best Catechol-O-Methyltransferase Inhibitor for parkinson disease
2 Catechol-O-Methyltransferase Inhibitor drugs indicated for parkinson disease, ranked by our independent rating. The current highest-rated is comtan. Compare them with all treatments for parkinson disease or the full Catechol-O-Methyltransferase Inhibitor class. Not medical advice — always consult a professional.
Top catechol-o-methyltransferase inhibitor for parkinson disease: 1. Comtan · 2. Tasmar
| # | Drug | Rating | Type | Typical price | |
|---|---|---|---|---|---|
| 1 | Comtan | Not yet rated | Prescription | $11 | View → |
| 2 | Tasmar | Not yet rated | Prescription | — | View → |
Full ranking · 2 drugs
comtan
PrescriptionFDA-sourced
Entacapone tablets USP is available as tablets containing 200 mg entacapone.
catechol-o-methyltransferase inhibitorparkinson disease
Typical price
~$10.65 /30
Frequently asked
- What is the best catechol-o-methyltransferase inhibitor for parkinson disease?
- By our independent rating, comtan currently ranks highest among Catechol-O-Methyltransferase Inhibitor drugs used for parkinson disease. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
- Which catechol-o-methyltransferase inhibitor drugs treat parkinson disease?
- pharmaranks lists 2 Catechol-O-Methyltransferase Inhibitor products indicated for parkinson disease, per FDA drug-label data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.